Peptone Company
We are the first in class pre-clinical translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered targets.
Investors
Founded Date:
2018-01-01
Technology:
Medical BioTech
Funding Status:
Early Stage Venture
Total Funding:
42443951.0
Employee Number:
1-10
Headquarters:
London, England, United Kingdom
Last Funding Date:
2022-06-09
Investors Number:
7.0
Last Funding Type:
Series A
Industry:
Medical BioTech